The 100,000 Genomes Club
10 Countries Meet the Mark for National Genome Projects
Supplement: Visions of a Continuous Bioprocess Future
Challenges Remain in the Switch from Fed-Batch Biomanufacturing Operations
This is Your Brain on DREADDs
Chemogenetics Provides a Noninvasive Tool for Precise Control of Neural Circuits
Scaling Up Cell Therapy Manufacturing
Moving Forward with an Early-on Strategy
For full access to this article login to GEN Select now.
Roslin Cells & Lonza Take On Stem Cell Media
Ultimate Goal of Initiatives Is to Facilitate Translation of Innovation into Regenerative Therapies
- Earlier this year Roslin Cells and Lonza signed a stem cell media development deal the firms hope will play a key role in the drive to translate scientific innovation in the stem cells field into clinically applied regenerative therapies. The agreement is centered on the development of clinical-grade ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.